$Actinium(ATNM)$
核药领域，迄今为止，共有6家被收购：
2024-03-19: FUSN (Fusion) acquired by AstraZeneca @ $2.4B
2023-12-26: RYZB (RayzeBio) acquired by BMS @$4.1B
2023-10-03: PNT (Point Biopharma) acquired by Eli Lily @$1.4B
2018-10-17: ECYT (Endocyte) acquired by Novartis @$2.1B
2017-11-03: AAA (Advanced Accelerator Applications) acquired by Novartis @$3.9B
2013-11-26: Algeta acquired by Bayer @$2.9B
买方：Top20药企里有5家已布局；可选的标的里：对比潜在空间，ATNM貌似👍，难怪今天涨幅最大。